Home › Funds › New York Life › NYLI PineStone Global Equity Fund
Fund family: New York Life · Filed by NEW YORK LIFE INVESTMENTS FUNDS TRUST (CIK 1469192) · SEC series S000081082
Share classes and tickers: FCGEX (C000243741), FCGIX (C000243739), FCGMX (C000243738), FCGPX (C000243737), FCGYX (C000243740)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 404 with, 26 against, 0 abstentions (not counted as with management). Shareholder proposals: 6 FOR, 19 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as New York Life’s manager page (58,397 ballot items across 52 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | New York Life | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 91.3% | 366 | 92.5% | 47,807 |
| Backed environmental and social shareholder proposals at US companies | n/a | 18 | 14.2% | 772 |
Each ballot item this fund voted is set against the votes of the other New York Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most New York Life funds on 43 items (12.7% of the 338 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most New York Life funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| PepsiCo, Inc. | 2026-05-06 | Election of Directors: Daniel Vasella | Against | FOR — 7 of 8 New York Life funds | Against | Elected, 91.7% support |
| Microsoft Corporation | 2025-12-05 | Shareholder Report on Data Operations in Human Rights Hotspots | Against | FOR — 10 of 13 New York Life funds | For | Failed (calculated), 27.5% support |
| Microsoft Corporation | 2025-12-05 | Shareholder Report on Human Rights Due Diligence | Against | FOR — 10 of 13 New York Life funds | For | Failed (calculated), 26.3% support |
| Johnson & Johnson | 2026-04-23 | Shareholder Independent Board Chair | For | AGAINST — 6 of 7 New York Life funds | Against | Failed (calculated), 23.4% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Clayton M. Magouyrk | Withhold | FOR — 6 of 7 New York Life funds | Against | Elected, 98.2% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Jeffrey O. Henley | Withhold | FOR — 6 of 7 New York Life funds | Against | Elected, 92.0% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Jeffrey S. Berg | Withhold | FOR — 6 of 7 New York Life funds | Against | Elected, 92.2% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Michael D. Sicilia | Withhold | FOR — 6 of 7 New York Life funds | Against | Elected, 98.3% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Michael J. Boskin | Withhold | FOR — 6 of 7 New York Life funds | Against | Elected, 91.3% support |
| CME Group Inc. | 2026-06-09 | 2 wordings Election of Equity Directors. Fourteen will be elected to the Board of Directors: Bryan T. Durkin | Against | FOR — 6 of 7 New York Life funds | Against | — |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: K. Ram Shriram | Against | FOR — 5 of 6 New York Life funds | Against | Elected, 95.2% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: L. John Doerr | Against | FOR — 5 of 6 New York Life funds | Against | Elected, 91.9% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Robin L. Washington | Against | FOR — 5 of 6 New York Life funds | Against | Elected, 94.7% support |
| The Sherwin-Williams Company | 2026-04-22 | Shareholder Shareholder Proposal Regarding Shareholder Ability to Call a Special Meeting | Against | FOR — 5 of 6 New York Life funds | For | Not approved, 43.3% support |
| PepsiCo, Inc. | 2026-05-06 | Shareholder Shareholder Proposal - Independent Board Chair. | For | AGAINST — 6 of 8 New York Life funds | Against | Not approved, 25.8% support |
| UnitedHealth Group Incorporated | 2026-06-01 | Shareholder If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. | For | AGAINST — 4 of 5 New York Life funds | Against | Not approved, 20.3% support |
| Alphabet Inc. | 2026-06-05 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock | For | AGAINST — 4 of 6 New York Life funds | For | Approved, 90.4% support |
| KEYENCE Corp. | 2026-06-12 | Approve Allocation of Income, with a Final Dividend of JPY 275 | Against | FOR — 3 of 4 New York Life funds | Against | — |
| KEYENCE Corp. | 2026-06-12 | Elect Director Nakata, Yu | Against | FOR — 3 of 4 New York Life funds | Against | — |
| KEYENCE Corp. | 2026-06-12 | Elect Director Terada, Kazuhiko | Against | FOR — 3 of 4 New York Life funds | Against | — |
| KEYENCE Corp. | 2026-06-12 | Elect Director Yamaguchi, Akiji | Against | FOR — 3 of 4 New York Life funds | Against | — |
| KEYENCE Corp. | 2026-06-12 | Elect Director Yamamoto, Hiroaki | Against | FOR — 3 of 4 New York Life funds | Against | — |
| UnitedHealth Group Incorporated | 2026-06-01 | Election of Directors: F. William McNabb III | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 97.1% support |
| UnitedHealth Group Incorporated | 2026-06-01 | Election of Directors: Timothy Flynn | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 95.4% support |
| Moody's Corporation | 2026-04-14 | Election of Directors: Vincent A. Forlenza | Against | FOR — 2 of 3 New York Life funds | Against | Passed (calculated), 95.6% support |
| Company | Meeting | Item | This fund | Most New York Life funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Otis Worldwide Corporation | 2026-05-27 | Shareholder Shareholder proposal regarding reporting on political contributions and expenditures | Against | FOR — 2 of 3 New York Life funds | For | Not approved, 45.6% support |
| Otis Worldwide Corporation | 2026-05-27 | Election of Directors: John H. Walker | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 97.2% support |
| Otis Worldwide Corporation | 2026-05-27 | Election of Directors: Nelda J. Connors | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 96.8% support |
| Otis Worldwide Corporation | 2026-05-27 | Election of Directors: Shelley Stewart, Jr. | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 97.2% support |
| Otis Worldwide Corporation | 2026-05-27 | Election of Directors: Thomas A. Bartlett | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 96.9% support |
| Copart, Inc. | 2025-12-05 | To elect the twelve nominees for director named in this proxy statement to hold office until our 2026 annual meeting of stockholders or until their respective successors have been duly elected and qualified: Steven D. Cohan | Against | FOR — 2 of 3 New York Life funds | Against | Elected, 88.4% support |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Compensation Report of Corporate Officers | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Compensation of Bernard Arnault, Chairman and CEO | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Approve Remuneration Policy of Chairman and CEO | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Authorize up to 1 Percent of Issued Capital for Use in Restricted Stock Plans | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Authorize up to 1 Percent of Issued Capital for Use in Stock Option Plans | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Delphine Arnault as Director | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Laurent Mignon as Director | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Marie-Josee Kravis as Director | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Reelect Natacha Valla as Director | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Renew Appointment of Diego Della Valle as Censor | For | AGAINST — 2 of 3 New York Life funds | For | — |
| LVMH Moet Hennessy Louis Vuitton SE | 2026-04-23 | Renew Appointment of Lord Powell of Bayswater as Censor | For | AGAINST — 2 of 3 New York Life funds | For | — |
Download all 43 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 60.0% of this fund’s 430 such votes could be given a sector; the other 172 (40.0%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 80 | 3 | 3.8% |
| Technology | 72 | 17 | 23.6% |
| Finance | 32 | 0 | 0.0% |
| Industrials | 29 | 0 | 0.0% |
| Health Care | 27 | 2 | 7.4% |
| Consumer Staples | 18 | 3 | 16.7% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 275 | 0 |
| Corporate Governance | 42 | 6 |
| Audit-related | 27 | 0 |
| Compensation | 25 | 0 |
| Capital Structure | 21 | 0 |
| Say-on-Pay | 18 | 0 |
| Other Social Issues | 14 | 12 |
| Environment or Climate | 3 | 3 |
| Human Rights or Human Capital/workforce | 3 | 3 |
| Shareholder Rights and Defenses | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Taiwan Semiconductor Manufacturing Co., Ltd. | June 4, 2026 | $4M | 3 | 0 |
| Alphabet Inc. | June 5, 2026 | $4M | 23 | 10 |
| Microsoft Corporation | December 5, 2025 | $3M | 21 | 6 |
| Mastercard Incorporated | June 16, 2026 | $3M | 15 | 2 |
| Moody's Corporation | April 14, 2026 | $2M | 12 | 0 |
| CME Group Inc. | June 9, 2026 | $2M | 20 | 0 |
| AutoZone, Inc. | December 17, 2025 | $2M | 13 | 0 |
| MSCI Inc. | April 21, 2026 | $2M | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposal | For | Against |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | For | Against |
| April 22, 2026 | The Sherwin-Williams Company | Shareholder Proposal Regarding Shareholder Ability to Call a Special Meeting Shareholder proposal | Against | For |
| May 6, 2026 | PepsiCo, Inc. | Shareholder Proposal - Independent Board Chair. Shareholder proposal | For | Against |
| May 6, 2026 | PepsiCo, Inc. | Shareholder Proposal - Report on Human Rights Oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Otis Worldwide Corporation | Shareholder proposal regarding reporting on political contributions and expenditures Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | For | Against |
430 ballot items at 27 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, NYLI PineStone Global Equity Fund (FCGEX) voted at 27 shareholder meetings of 27 companies, on 430 ballot items in all. Where management made a recommendation, the fund followed it on 94.0% of the items and voted against it 26 times. Its most frequent area of disagreement was other social issues (12 of its votes against management). It voted on 25 shareholder proposals. It voted FOR the board's own proposals less often than New York Life's funds as a whole (91.3% against 92.5%). It voted differently from most New York Life funds on 43 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of New York Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.